Cargando…
Venlafaxine treatment reduces the deficit of executive control of attention in patients with major depressive disorder
Attention plays an essential role in supporting other cognitive functions and behavior, and disturbance of attention is one of the most common symptoms in major depressive disorder (MDD). Although treatment with venlafaxine for MDD symptoms has been shown to reduce deficits in cognition and emotion...
Autores principales: | Tian, Yanghua, Du, Jing, Spagna, Alfredo, Mackie, Melissa-Ann, Gu, Xiaosi, Dong, Yi, Fan, Jin, Wang, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910055/ https://www.ncbi.nlm.nih.gov/pubmed/27306061 http://dx.doi.org/10.1038/srep28028 |
Ejemplares similares
-
Supramodal executive control of attention
por: Spagna, Alfredo, et al.
Publicado: (2015) -
Cognitive Considerations in Major Depression: Evaluating the Effects of Pharmacotherapy and ECT on Mood and Executive Control Deficits
por: Spagna, Alfredo, et al.
Publicado: (2022) -
Uncontrolled Self-Medication with Venlafaxine in a Patient with Major Depressive Disorder
por: Song, Ji-Hye, et al.
Publicado: (2011) -
Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder
por: Ye, Wenyu, et al.
Publicado: (2011) -
The cost-utility of maintenance treatment with venlafaxine in patients with recurrent major depressive disorder
por: Sobocki, P, et al.
Publicado: (2008)